Literature DB >> 8453267

Recent advances in retrovirus vector technology.

K A Boris-Lawrie1, H M Temin.   

Abstract

Retroviral vectors are widely used for the study of retroviral replication and to introduce DNA into somatic cells. An exciting new approach in retroviral vector technology is the use of internal ribosome entry sites from picornaviruses to provide stable expression of multiple genes. In addition, strategies are being developed that target the expression of retroviral vectors to specific cell populations.

Mesh：

Year:  1993        PMID： 8453267     DOI： 10.1016/s0959-437x(05)80349-1

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN： 0959-437X            Impact factor:   5.578


  11 in total

1.  Recombination between two identical sequences within the same retroviral RNA molecule.

Authors:  J Zhang; C M Sapp
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Most retroviral recombinations occur during minus-strand DNA synthesis.

Authors:  J Zhang; L Y Tang; T Li; Y Ma; C M Sapp
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Determination of the frequency of retroviral recombination between two identical sequences within a provirus.

Authors:  T Li; J Zhang
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Evidence for retroviral intramolecular recombinations.

Authors:  J Zhang; Y Ma
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 5.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

6.  Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line.

Authors:  G W Holzer; F G Falkner
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Production of high titre helper-free recombinant retroviral vectors by lipofection.

Authors:  A Fassati; Y Takahara; F S Walsh; G Dickson
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

8.  Exogenous Mtv-7 superantigen transgene expression in major histocompatibility complex class II I-E- mice reconstituted with embryonic stem cell-derived hematopoietic stem cells.

Authors:  C A Chambers; J Kang; J Pawling; B Huber; N Hozumi; A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses.

Authors:  M Duch; K Paludan; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: production of an ADA-deficient homozygote ES cell line.

Authors:  S Vaulont; S Daines; M Evans
Journal:  Transgenic Res       Date:  1995-07       Impact factor: 2.788
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.